Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication

Saved in:
Bibliographic Details
Published in:Haematologica - the Hematology journal
Format: Online Article RSS Article
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552932278927360
collection WordPress RSS
FRELIP Feed Integration
container_title Haematologica - the Hematology journal
description
discipline_display Hematology
discipline_facet Hematology
format Online Article
RSS Article
genre Journal Article
id rss_article:69087
institution FRELIP
journal_source_facet Haematologica - the Hematology journal
last_indexed 2026-06-20T21:28:52.253Z
publishDate 2025
publishDateSort 2025
record_format rss_article
spellingShingle Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication
Hematology
General
Hematology
sub_discipline_display General
sub_discipline_facet General
subject_display Hematology
General
Hematology
subject_facet Hematology
General
Hematology
title Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication
title_alt Ensayo de fase II aleatorizado multicéntrico inicial de quizartinib y citarabina en dosis altas más mitoxantrona en leucemia mieloide aguda recidivante/refractaria con duplicación interna en tándem de tirosina quinasa tipo FMS
Essai de phase II randomisé multicentrique upfront de quizartinib et de cytarabine haute dose plus mitoxantrone dans la leucémie aiguë myéloïde réfractaire/récidivante avec duplication interne en tandem de FMS-like tyrosine kinase 3
Ensaio randomizado multicêntrico de fase II upfront de quizartinibe e citarabina em altas doses mais mitoxantrona na leucemia mieloide aguda recidivada/refratária com duplicação interna em tandem do receptor tirosina quinase tipo FMS 3
title_auth Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication
title_es_txt Ensayo de fase II aleatorizado multicéntrico inicial de quizartinib y citarabina en dosis altas más mitoxantrona en leucemia mieloide aguda recidivante/refractaria con duplicación interna en tándem de tirosina quinasa tipo FMS
title_fr_txt Essai de phase II randomisé multicentrique upfront de quizartinib et de cytarabine haute dose plus mitoxantrone dans la leucémie aiguë myéloïde réfractaire/récidivante avec duplication interne en tandem de FMS-like tyrosine kinase 3
title_full Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication
title_fullStr Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication
title_full_unstemmed Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication
title_pt_txt Ensaio randomizado multicêntrico de fase II upfront de quizartinibe e citarabina em altas doses mais mitoxantrona na leucemia mieloide aguda recidivada/refratária com duplicação interna em tandem do receptor tirosina quinase tipo FMS 3
title_short Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication
title_sort multicenter upfront randomized phase ii trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with fmslike tyrosine kinase 3 internal tandem duplication
topic Hematology
General
Hematology
url https://haematologica.org/article/view/13000